Invesco Ltd. Molecular Templates, Inc. Transaction History

Invesco Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.81 - $3.43 $11,183 - $47,358	-13,807 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.27 - $4.13 $245 - $446	108 Added 0.79%	13,807 $48,000
Q4 2021 Feb 14, 2022	SELL	$3.37 - $6.87 $8,576 - $17,484	-2,545 Reduced 15.67%	13,699 $54,000
Q3 2021 Nov 15, 2021	BUY	$5.78 - $7.86 $18,900 - $25,702	3,270 Added 25.2%	16,244 $109,000
Q2 2021 Aug 17, 2021	BUY	$7.82 - $12.44 $101,456 - $161,396	12,974 New	12,974 $101,000
Q4 2020 Feb 16, 2021	SELL	$8.48 - $12.23 $777,573 - $1.12 Million	-91,695 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$9.99 - $14.41 $756,462 - $1.09 Million	75,722 Added 474.06%	91,695 $1 Million
Q2 2020 Aug 14, 2020	SELL	$12.28 - $17.63 $740,950 - $1.06 Million	-60,338 Reduced 79.07%	15,973 $220,000
Q1 2020 May 15, 2020	SELL	$11.31 - $18.26 $177,555 - $286,663	-15,699 Reduced 17.06%	76,311 $1.02 Million
Q4 2019 Feb 14, 2020	BUY	$6.44 - $14.21 $592,544 - $1.31 Million	92,010 New	92,010 $1.29 Million

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $10.1M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.